Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at high risk of developing cardiovascular disease
(CVD). Inflammation has a pivotal role in the pathogenesis of CVD. RA is an inflammatory …
(CVD). Inflammation has a pivotal role in the pathogenesis of CVD. RA is an inflammatory …
All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study
…, S Rollefstad, S Lillegraven, J Sexton, G Wibetoe… - …, 2022 - academic.oup.com
Objectives To explore mortality and causes of death among Norwegian patients with RA, PsA
and axial spondyloarthritis (axSpA) compared with the general population by conducting a …
and axial spondyloarthritis (axSpA) compared with the general population by conducting a …
Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis
Objective. We evaluated the predictive value of these vascular biomarkers for cardiovascular
disease (CVD) events in patients with rheumatoid arthritis (RA): aortic pulse wave velocity (…
disease (CVD) events in patients with rheumatoid arthritis (RA): aortic pulse wave velocity (…
[HTML][HTML] Cardiovascular disease risk profiles in inflammatory joint disease entities
Background Patients with inflammatory joint diseases (IJD) have increased risk of
cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, …
cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, …
Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients
IK Roelsgaard, E Ikdahl, S Rollefstad, G Wibetoe… - …, 2020 - academic.oup.com
Objectives Smoking is a major risk factor for the development of both cardiovascular disease
(CVD) and RA and may cause attenuated responses to anti-rheumatic treatments. Our aim …
(CVD) and RA and may cause attenuated responses to anti-rheumatic treatments. Our aim …
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents
…, S Rollefstad, A Kazemi, G Wibetoe… - Scandinavian Journal …, 2023 - Taylor & Francis
Objective To estimate the prevalence of psoriatic arthritis (PsA), axial spondyloarthritis (axSpA)
and rheumatoid arthritis (RA) and the use of biologic agents in these diseases in Norway. …
and rheumatoid arthritis (RA) and the use of biologic agents in these diseases in Norway. …
Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
E Ikdahl, G Wibetoe, S Rollefstad, A Salberg… - International journal of …, 2019 - Elsevier
Objectives Patients with inflammatory joint diseases (IJD) have an increased risk of
cardiovascular disease (CVD). Our goal was to examine indications for, and use of, lipid-lowering …
cardiovascular disease (CVD). Our goal was to examine indications for, and use of, lipid-lowering …
Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway
AM Kerola, J Sexton, G Wibetoe, S Rollefstad… - Seminars in Arthritis and …, 2021 - Elsevier
Objectives To evaluate nationwide incidence, sociodemographic associations and treatment
penetration of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in Norway. Methods The …
penetration of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in Norway. Methods The …
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Aim The objective was to examine the prevalence of atherosclerotic cardiovascular disease
(ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and …
(ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and …
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries
S Rollefstad, E Ikdahl, G Wibetoe… - European Heart …, 2022 - academic.oup.com
Aims To assess differences in estimated cardiovascular disease (CVD) risk among rheumatoid
arthritis (RA) patients from different world regions and to evaluate the management and …
arthritis (RA) patients from different world regions and to evaluate the management and …